Novel Reassortants of Oropouche Virus (OROV) Are Causing Maternal-Fetal Infection During Pregnancy, Stillbirth, Congenital Microcephaly and Malformation Syndromes

被引:7
作者
Schwartz, David A. [1 ]
机构
[1] Perinatal Pathol Consulting, 490 Dogwood Valley Dr, Atlanta, GA 30342 USA
关键词
Oropouche virus; Oropouche fever; orthobunyavirus; vertical infection; reassortant; arbovirus; epidemic; fetal death; miscarriage; malformation syndrome; microcephaly; Brazil; congenital infection; EPIDEMIOLOGY; FEVER;
D O I
10.3390/genes16010087
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Oropouche virus (OROV) is an orthobunyavirus endemic in the Brazilian Amazon that has caused numerous outbreaks of febrile disease since its discovery in 1955. During 2024, Oropouche fever spread from the endemic regions of Brazil into non-endemic areas and other Latin American and Caribbean countries, resulting in 13,014 confirmed infections. Similarly to other orthobunyaviruses, OROV can undergo genetic reassortment events with itself as well as other viruses. This occurred during this current outbreak, resulting in novel strains with increased pathogenicity and levels of transmission. For the first time, pregnant women with Oropouche fever have sustained poor perinatal outcomes, including miscarriage, fetal demise, stillbirths and malformation syndromes including microcephaly. In July 2024, PAHO issued an Epidemiological Alert warning of the association of OROV with vertical transmission. OROV has now been identified in the fetal blood, cerebrospinal fluid, placenta and umbilical cords, and fetal somatic organs including the liver, kidneys, brain, spleen, heart, and lungs using nucleic acid and antigen testing. Perinatal autopsy pathology has confirmed central nervous system infection from OROV in infants with congenital infection including microcephaly, ventriculomegaly, agenesis of corpus callosum, and neuronal necrosis. The latest data from Brazil show 3 confirmed cases of OROV vertical transmission; 2 cases of fetal death; 1 case of congenital malformation; and ongoing investigations into the role of OROV in 15 cases of fetal death, 3 cases of congenital malformations and 5 spontaneous miscarriages. This Commentary discusses the mechanisms and significance of development of novel reassortant strains of OROV during the current outbreak and their recent recognition as causing vertical infection and adverse perinatal outcomes among pregnant women with Oropouche fever.
引用
收藏
页数:13
相关论文
共 63 条
[1]   Iquitos Virus: A Novel Reassortant Orthobunyavirus Associated with Human Illness in Peru [J].
Aguilar, Patricia V. ;
Barrett, Alan D. ;
Saeed, Mohammad F. ;
Watts, Douglas M. ;
Russell, Kevin ;
Guevara, Carolina ;
Ampuero, Julia S. ;
Suarez, Luis ;
Cespedes, Manuel ;
Montgomery, Joel M. ;
Halsey, Eric S. ;
Kochel, Tadeusz J. .
PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (09)
[2]  
American College of Obstetricians and Gynecologists, Update on Oropouche Virus and Potential Effects on Pregnancy
[3]   Oropouche Virus Spreads to New Regions in Latin America [J].
Anderer, Samantha .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 332 (12)
[4]   Oropouche fever, the mysterious threat [J].
不详 .
LANCET INFECTIOUS DISEASES, 2024, 24 (09) :935-935
[5]   Epidemiology of endemic Oropouche virus transmission in upper Amazonian Peru [J].
Baisley, KJ ;
Watts, DM ;
Munstermann, LE ;
Wilson, ML .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 59 (05) :710-716
[6]  
Borborema C A, 1982, Rev Inst Med Trop Sao Paulo, V24, P132
[7]  
Brazil Ministry of Health Ministerio da Saude, 2024, Informa caso de Anomalia Congenita Associada a Oropouche
[8]   Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis [J].
Bridgen, A ;
Weber, F ;
Fazakerley, JK ;
Elliott, RM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (02) :664-669
[9]   Unprecedented spread and genetic evolution of the Oropouche virus [J].
Castro, Marcia C. ;
Neto, Antonio Silva Lima .
NATURE MEDICINE, 2024, 30 (12) :3420-3421
[10]  
Centers for Disease Control and Prevention, 2024, Interim clinical considerations for use of vaccine for mpox prevention in the United States | mpox | CDC